Home > Newsletters > FDAnews Drug Daily Bulletin > FDA Submits Generic, Brand Drug User Fee Bill Language to Congress
FDAnews Drug Daily Bulletin
Jan. 18, 2012 | Vol. 9 No. 12
FDA Submits Generic, Brand Drug User Fee Bill Language to Congress
Generic drugmakers won’t have long to wait after Congress passes a user fee bill to learn the various fee levels in the Generic Drug User Fee Act (GDUFA). Under statutory language delivered to Capitol Hill on Friday, the FDA would have only until Oct. 31 to establish fee levels for a one-time backlog fee, a drug master file fee and various application and supplement fees.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.